McColl Partners, LLC acted as financial advisor to etrials, Inc. ("etrials"), a provider of clinical trial automation technology, on its merger with Araccel Corporation.  The merger, combining two eClinical solutions providers, forms etrials Worldwide, an international leader in software and services for the efficient collection, analysis, and integration of data in clinical drug trials.  By streamlining the drug discovery process, industry experts estimate etrials Worldwide's automation technology can save pharmaceutical companies more than $1 million per day and shorten the length of clinical trials on average by three months.

About etrials, Inc.

etrials has earned the loyalty of its health care partners by guiding them to simplify and accelerate the processes associated with collecting, analyzing, and integrating data in clinical trials.  Using innovative software technologies and proven business processes, etrials offers an efficient eClinical platform and comprehensive services for managing quantitative and qualitative study data.  etrials leads pharmaceutical and biotechnology companies through the critical processes involved in turning a technology into a solution, successfully migrating clients from paper-based to electronic data management methods. 

About McColl Partners, LLC

McColl Partners is an independent investment banking firm specializing in the needs of management and owners of middle-market companies.  With significant experience working with private equity groups, entrepreneurs, family-owned businesses, public companies, financial institutions, and divisions of large companies, the firm is dedicated to offering strategic advice and assistance to its clients regarding mergers and acquisitions and private capital raising assignments.

For more information about our Healthcare Group, please contact Dave Vorhoff at (704) 333-0525.  More information about McColl Partners can be found at www.mccollpartners.com.